Form 8-K - Current report:
SEC Accession No. 0001188112-06-002377
Filing Date
2006-08-08
Accepted
2006-08-08 14:55:52
Documents
4
Period of Report
2006-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K t11211_8k.htm 8-K 54268
2 EXHIBIT 2.1 ex2-1.htm EX-2.1 633048
3 EXHIBIT 10.1 ex10-1.htm EX-10.1 498557
4 EXHIBIT 10.2 ex10-2.htm EX-10.2 98976
  Complete submission text file 0001188112-06-002377.txt   1286866
Mailing Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518
Business Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518 7702710233
THERAGENICS CORP (Filer) CIK: 0000795551 (see all company filings)

EIN.: 581528626 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14339 | Film No.: 061012554
SIC: 3825 Instruments For Meas & Testing of Electricity & Elec Signals